Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Atr Fibrillation ; 14(2): 20200475, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34950369

RESUMO

BACKGROUND: The efficacy of posterior wall isolation (PWI) on top of pulmonary vein isolation (PVI) in patients affected by persistent atrial fibrillation (AF) is still controversial and little is known about the impact of contact-force (CF) technology. OBJECTIVE: In this retrospective study, we present our experience with PWI using CF sensing catheters and its efficacy and safety as an adjunctive ablation strategy on top of PVI for management of patients with persistent and longstanding persistent AF. METHODS: A total of 73 consecutive patients (20.5% female) affected by persistent atrial fibrillation (10.9% long-standing) underwent PWI as an adjunctive therapy to PVI using CF sensing catheters. Outcomes were reported as incidence of atrial arrhythmic recurrences (ARs) lasting >30 seconds at follow up and in addition, in patients provided with insertable cardiac monitors (ICM), as burden of AF or atrial tachycardias (AT) at relevant time points. RESULTS: PWI was successfully achieved in 65 (89.0%) patients. Two (2.7%) minor vascular procedural complications were observed. At 1 and 2-year follow-up, ARs free survival was observed in 80.5% and 64.1% of patients, respectively with 75.3% of patients off antiarrhythmic drugs at the last follow-up. Ten patients underwent repeat ablations during the follow-up. At multivariate analysis, early ARs within 3 months after procedure, were associated with a two-fold increased risk of late ARs at follow-up. Among patients provided with ICM, PWI on top of PVI was able to reduce the mean AT/AF burden of more than 50% compared with pre-ablation time, reporting very low levels (≤ 5%) over 2 years. CONCLUSIONS: In persistent atrial fibrillation, PWI on top of PVI using CF sensing catheters is safe and effective, providing great reduction of burden of ARs. Early ARs are associated with a greater risk of late recurrences.

2.
Cardiovasc Ultrasound ; 8: 11, 2010 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-20380731

RESUMO

BACKGROUND: Dynamic intraventricular obstruction has been observed in patients with left ventricular ballooning syndrome (LVBS) and has been hypothesized as a possible mechanism of the syndrome. The aim of this study was to assess the prevalence and significance of dynamic intraventricular obstruction in patients with LVBS. METHODS AND RESULTS: Dobutamine stress echocardiography was carried out in 22 patients with LVBS (82% apical), all women, aged 68 +/- 9 years. At baseline 1 patient had a > 30 mmHg LV gradient; during stress a LV gradient > 30 mm Hg developed in 6/21 patients (28%) and was caused by systolic anterior motion of the mitral valve in the 3 patients with severe gradient (mean 116 +/- 29 mmHg), who developed mitral regurgitation and impaired apical wall motion and by obstruction at mid-ventricular level in the other 3 with a moderate gradient (mean 46 +/- 16 mmHg). Compared with patients without obstruction those with obstruction had a greater mean septal thickness (11.6 +/- .6 vs 9.8. +/- 3, p < .01), a higher prevalence of septal hypertrophy (71% vs 7%, p < .005) and a higher peak wall motion score index (1.62 +/- .4 vs 1.08 +/- .4, p < .01). CONCLUSION: Spontaneous or dobutamine-induced dynamic LV obstruction is documented in 32% of patients with LVBS, is correlated with the presence of septal hypertrophy and may play a role in the development of LVBS in this subset of patients. In those without septal hypertrophy a dynamic obstruction is rarely induced with dobutamine and is unlikely to be a major pathogenetic factor of the syndrome.


Assuntos
Ecocardiografia sob Estresse , Insuficiência da Valva Mitral/diagnóstico por imagem , Cardiomiopatia de Takotsubo/diagnóstico por imagem , Obstrução do Fluxo Ventricular Externo/diagnóstico por imagem , Idoso , Idoso de 80 Anos ou mais , Cardiotônicos , Angiografia Coronária , Dobutamina , Feminino , Humanos , Pessoa de Meia-Idade , Insuficiência da Valva Mitral/epidemiologia , Prevalência , Cardiomiopatia de Takotsubo/epidemiologia , Obstrução do Fluxo Ventricular Externo/epidemiologia
3.
J Cardiovasc Electrophysiol ; 20(1): 22-8, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18775050

RESUMO

INTRODUCTION: Atrial fibrillation (AF) and diabetes mellitus type 2 (DM2) often coexist; however, a small number of patients with DM2 undergoing catheter ablation (CA) of AF have been included in previous studies. The aim of this study was to evaluate safety and efficacy of ablation therapy in DM2 patients with drug refractory AF. METHODS AND RESULTS: From January 2005 to September 2006, 70 patients with a diagnosis of DM2 and paroxysmal (n = 29) or persistent (n = 41) AF were randomized to receive either pulmonary vein isolation or a new antiarrhythmic drug treatment (ADT) with a 1-year follow-up. The primary endpoint was the time to first AF recurrence. By Kaplan-Meier analysis, at the end of follow-up, 42.9% of patients in the ADT group and 80% of patients who received a single ablation procedure and were without medications were free of AF (P = 0.001). In the ablation group, a significant improvement in quality-of-life (QoL) scores as compared with ADT group was observed. Six patients in the ADT group (17.1%) developed significant adverse drug effects. Hospitalization rate during follow-up was higher in the ADT group (P = 0.01). The only complication attributable to ablation was one significant access-site hematoma. CONCLUSION: In patients with DM2, CA of AF provides significant clinical benefits over the ADT and appears to be a reasonable approach regarding feasibility, effectiveness, and low procedural risk.


Assuntos
Antiarrítmicos/uso terapêutico , Fibrilação Atrial/complicações , Fibrilação Atrial/terapia , Ablação por Cateter/métodos , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/terapia , Sistema de Condução Cardíaco/cirurgia , Veias Pulmonares/cirurgia , Feminino , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
4.
J Cardiovasc Med (Hagerstown) ; 14(7): 528-33, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22885532

RESUMO

BACKGROUND: Radiofrequency catheter ablation (RFCA) of atrial fibrillation is an effective and definitive treatment. The methods used to guide RFCA have evolved over the years from a purely electrophysiological approach, in which anatomical lesions were guided solely by fluoroscopy and angiographic imaging of the pulmonary veins, to an approach guided by modern nonfluoroscopic electroanatomical mapping, integrated or not with computed tomography (CT). The aim of this study was, therefore, to compare radiation exposure of RFCA based on a fast three-dimensional nonfluoroscopic mapping system with 'traditional' mapping integrated with CT imaging. METHODS: Thirty consecutive patients with atrial fibrillation who underwent RFCA were treated with two different approaches: 3D-Fast-Anatomical-Mapping and One-Map tool (FAM-One Map group, 21 patients) vs. 3D-Fast-Anatomical-Mapping integrated with CT images (MERGE-CT group, nine patients). Fluoroscopy time and radiation doses (expressed in milliGray) were compared. RESULTS: No statistically significant difference was detectable between FAM-One Map group and MERGE-CT group considering RFCA success rates and fluoroscopy times. Radiation exposure was higher in the MERGE-CT group (965 ±â€Š138  mGy MERGE-CT group vs. 532 ±â€Š216  mGy FAM-One Map group, P < 0.001) because of supplemental radiation exposures due to CT imaging (470 ±â€Š126  mGy). CONCLUSION: A fast nonfluoroscopic electroanatomical mapping system may reduce radiation exposure in RFCA of atrial fibrillation, with preserved success rates.


Assuntos
Fibrilação Atrial/cirurgia , Ablação por Cateter/métodos , Doses de Radiação , Feminino , Fluoroscopia/métodos , Humanos , Imageamento Tridimensional/métodos , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
5.
Int J Cardiol ; 168(4): 3968-70, 2013 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-23886532

RESUMO

Whether and to what extent patients with asymptomatic atrial fibrillation (AF) would benefit from catheter ablation has not been investigated. This is the first multicenter prospective study reporting on the outcome of catheter ablation in patients with asymptomatic AF. Consecutive patients (n = 545) referred for AF ablation were prospectively enrolled in a multicenter Italian registry. Of these patients, 54 have asymptomatic AF and composed our patient population. At 24 month follow-up, catheter ablation in asymptomatic AF patients resulted to be as safe and effective as in patients with drug refractory symptomatic AF. Our study provides significant insights on the role of AF ablation in asymptomatic patients. Further studies in much larger cohorts are needed to validate our conclusions.


Assuntos
Doenças Assintomáticas/epidemiologia , Doenças Assintomáticas/terapia , Fibrilação Atrial/epidemiologia , Fibrilação Atrial/cirurgia , Ablação por Cateter/métodos , Sistema de Registros , Idoso , Estudos de Coortes , Intervalo Livre de Doença , Feminino , Seguimentos , Humanos , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Resultado do Tratamento
7.
Int J Cardiol ; 134(1): 91-6, 2009 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-18508143

RESUMO

BACKGROUND: Left ventricular apical ballooning syndrome (LVABS) is a cardiac syndrome mimicking acute myocardial infarction, whose prevalence in western populations and pathogenesis are not yet well defined. The aim of the study was to assess its prevalence, clinical characteristics and pathophysiological mechanisms in a European population of myocardial infarction patients. METHODS: Of a series of 1457 patients with acute myocardial infarction 18 fulfilled the diagnostic criteria for LVABS. To evaluate the pathogenetic mechanisms we studied coronary blood flow with TIMI flow grade and corrected TIMI frame count (CTFC) in all patients and performed provocative testing with ergonovine and dobutamine echocardiography in 14. RESULTS: All patients were women aged 72+/-9 years. A triggering event was identifiable in 39% of cases. LV ejection fraction in the acute phase was 46+/-5%. No deaths or major complications occurred during hospitalization. Response to ergonovine was negative in all 14 patients and dobutamine induced a dynamic LV obstruction in 4/14 (28%). Mean CTFC was abnormally prolonged in all 3 major coronary arteries and 16/18 patients (89%) had an abnormal CTFC in >/=1 coronary vessel. No cardiac deaths occurred during follow-up and 1 patient only had a recurrence. CONCLUSIONS: The prevalence of LVABS is 1.2% among all patients with acute myocardial infarction, but rises to 4.9% in women. Short- and long-term prognosis is good. Abnormal CTFC suggests the presence of a coronary microvascular dysfunction, while dynamic LV obstruction can contribute to the development of LVABS in a minority of patients.


Assuntos
Cardiomiopatia de Takotsubo/etnologia , Cardiomiopatia de Takotsubo/etiologia , População Branca/estatística & dados numéricos , Idoso , Idoso de 80 Anos ou mais , Cardiotônicos , Circulação Coronária/efeitos dos fármacos , Circulação Coronária/fisiologia , Dobutamina , Ecocardiografia , Ergonovina , Feminino , Seguimentos , Humanos , Microcirculação/efeitos dos fármacos , Microcirculação/fisiologia , Pessoa de Meia-Idade , Infarto do Miocárdio/etnologia , Infarto do Miocárdio/etiologia , Infarto do Miocárdio/fisiopatologia , Ocitócicos , Prevalência , Fatores de Risco , Cardiomiopatia de Takotsubo/fisiopatologia , Função Ventricular Esquerda/efeitos dos fármacos , Função Ventricular Esquerda/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA